檢索結果 - Wanli Lin
- Showing 1 - 4 results of 4
-
1
-
2
-
3
Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (<scp>NIC‐ESCC2019</scp>): A multicenter, phase 2 study 由 Jun Liu, Jingpei Li, Wanli Lin, Ди Шао, Lieven Depypere, Zhifeng Zhang, Zhuoyi Li, Fei Cui, Ze-Sen Du, Yuan Zeng, Shunjun Jiang, Ping He, Xia Gu, Huai Chen, Hai Zhang, Xiaowei Lin, Haoda Huang, Wenqiang Lv, Wei-Ming Cai, Wenhua Liang, Hengrui Liang, Wenxi Jiang, Wei Wang, Ke Xu, Weipeng Cai, Kui Wu, Antoon Lerut, Junhui Fu, Jianxing He
出版 2022Artigo -
4
IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment 由 Gilbert Aaron Lee, Justin Bo‐Kai Hsu, Yu-Wei Chang, Li-Chun Hsieh, Yi-Tien Li, Ying Chieh Wu, Cheng-Ying Chu, Yung‐Hsiao Chiang, Wan-Yuo Guo, Chien‐Wei Wu, Liang-Wei Chen, Hung‐Wen Kao, Wanli Lin, Li‐Wen Tseng, Ting-Wei Weng, Duen-Pang Kuo, Sho-Jen Cheng, Yung-Chieh Chen, Shiu‐Wen Huang, Hsing-Jien Kung, Cheng‐Yu Chen
出版 2025Artigo
相關主題
Medicine
Internal medicine
Biology
Cancer
Cancer research
Immune system
Immunology
Oncology
Adenocarcinoma
Allele
Basal cell
Breast cancer
CINAHL
Carcinoma
Chemotherapy
Clinical psychology
Confidence interval
Cytokine
Demography
Esophageal disease
Esophageal squamous cell carcinoma
Esophagus
Gene
Genetics
Inflammasome
Innate immune system
Law
MEDLINE
Meta-analysis
Microsatellite